Comparison of immune checkpoint inhibitor plus chemotherapy or ipilimumab plus nivolumab-based therapy for NSCLC patients with PD-L1 TPS (1-49 %): TOPGAN2023-01.

Autor: Tanaka H; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Electronic address: xyghx335@mail.com., Makiguchi T; Department of Respiratory Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan., Tozuka T; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan., Kawashima Y; Department of Pulmonary Medicine, Sendai Kousei Hospital, Sendai, Japan., Oba T; Department of Respiratory Medicine, Saitama Red Cross Hospital, Saitama, Japan., Tsugitomi R; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan., Koyama J; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan., Tambo Y; Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan., Ogusu S; Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan., Saiki M; Department of Respiratory Medicine, Graduate School of Medicine University of Yamanashi, Yamanashi, Japan., Gyotoku H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Hasegawa T; Division of Respiratory Disease, Department of Internal Medicine, The Jikei University Daisan Hospital, Tokyo, Japan., Miyauchi E; Department of Respiratory Medicine, Tohoku University Hospital, Sendai, Japan., Sonoda T; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan., Saito R; Department of Respiratory Medicine, Yamanashi Prefectural Central Hospital, Yamanashi, Japan., Nakatomi K; Department of Respiratory Medicine, National Hospital Organization Ureshino Medical Center, Nagasaki, Japan., Sakatani T; Division of Respiratory Medicine, NTT Medical Center Tokyo, Tokyo, Japan., Kudo K; Department of Medical Oncology and Respiratory Medicine, National Hospital Organization Osaka Minami Medical Center, Osaka, Japan., Tsuchiya-Kawano Y; Department of Respiratory Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan., Nishio M; Department of Thoracic Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Nov 05; Vol. 213, pp. 115117. Date of Electronic Publication: 2024 Nov 05.

TIM-3 expression induces resistance to PD-1 inhibitor in G-CSF-producing lung spindle cell carcinoma: A case report.

Autor: Hayashi F; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan., Akagi K; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan., Taniguchi H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan., Matsutake T; Department of Respiratory Medicine, Kouseikai Hospital, Nagasaki, Japan., Kawahara H; Department of Internal Medicine, Kouseikai Hospital, Nagasaki, Japan., Sekine I; Department of Pathology, Kouseikai Hospital, Nagasaki, Japan., Gyotoku H; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Takemoto S; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Soda H; Department of Respiratory Medicine, Sasebo City General Hospital, Sasebo, Japan., Ashizawa K; Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan.; Department of Clinical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Mukae H; Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Publikováno v: Thoracic cancer [Thorac Cancer] 2023 Dec; Vol. 14 (36), pp. 3556-3560. Date of Electronic Publication: 2023 Nov 05.

EP.11A.16 Infusion Timing of ICI Monotherapy in Patients with Advanced NSCLC: A Single Institution-Retrospective Study.

Autor: Tagawa, R., Takemoto, S., Gyotoku, H., Taniguchi, H., Matsuo, M., Tomono, H., Akagi, K., Ono, S., Hayashi, F., Fukuda, T., Mukae, H.

Publikováno v: Journal of Thoracic Oncology; 2024 Supplement, Vol. 19 Issue 10, pS602-S603, 2p

1924P Efficacy and safety of lenvatinib in patients with chemotherapy-naive advanced or recurrent thymic carcinoma: A multicenter retrospective study

Autor: Hazama, D., Takagi, K., Saito, G., Tsugitomi, R., Ashinuma, H., Shukuya, T., Gyotoku, H., Sakata, S., Mouri, A., Miwa, H., Tamura, Y., Tokito, T., Tsukita, Y., Kogure, Y., Masuda, T., Tanaka, H., Kubo, S., Suzuki, T.

Publikováno v: In Annals of Oncology September 2024 35 Supplement 2:S1119-S1119

Phase II study of IRInotecan treatment after COmbined chemo-immunotherapy for extensive-stage small cell lung cancer: Protocol of IRICO study.

Autor: Tomono H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan., Taniguchi H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan., Fukuda M; Clinical Oncology Center, Nagasaki University Hospital, Nagasaki, Japan.; Department of Respiratory Medicine, Nagasaki Prefecture Shimabara Hospital, Nagasaki, Japan., Ikeda T; Department of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan., Nagashima S; Department of Respiratory Medicine, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan., Akagi K; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Ono S; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Umeyama Y; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Shimada M; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Gyotoku H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Takemoto S; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Hisamatsu Y; Department of Thoracic Medical Oncology, Oita Prefectural Hospital, Oita, Japan., Morinaga R; Department of Thoracic Medical Oncology, Oita Prefectural Hospital, Oita, Japan., Tagawa R; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan., Ogata R; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan., Dotsu Y; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan., Senju H; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan.; Department of Internal Medicine, Senju Hospital, Nagasaki, Japan., Soda H; Department of Respiratory Medicine, Sasebo City General Hospital, Nagasaki, Japan., Nakatomi K; Department of Respiratory Medicine, National Hospital Organization Ureshino Medical Center, Saga, Japan., Hayashi F; Department of Respiratory Medicine, Nagasaki Prefecture Shimabara Hospital, Nagasaki, Japan., Sugasaki N; Department of Respiratory Medicine, Nagasaki Prefecture Shimabara Hospital, Nagasaki, Japan., Kinoshita A; Department of Respiratory Medicine, Nagasaki Prefecture Shimabara Hospital, Nagasaki, Japan., Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Publikováno v: Thoracic cancer [Thorac Cancer] 2023 Oct; Vol. 14 (28), pp. 2890-2894. Date of Electronic Publication: 2023 Sep 07.